Pharmaceutical

GE HealthCare to announce second quarter 2025 results on July 30, 2025

CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) will announce its second quarter 2025 financial results before the market opens on Wednesday, July…

6 months ago

Health Union Unveils Innovative 2026 DTC Product Suite, Revolutionizing Patient Engagement with AI and Dynamic Experiences

PHILADELPHIA, July 7, 2025 /PRNewswire/ -- Health Union, the leading digital health company for online community-based activation and data, is…

6 months ago

Doctors Are Being Outpaced by AI-Powered Algorithms — Here’s What It Means for Investors

USA News Group News CommentaryIssued on behalf of Avant Technologies Inc. VANCOUVER, BC, July 7, 2025 /PRNewswire/ -- USA News…

6 months ago

VIOME COLLABORATES WITH MICROSOFT TO DELIVER PREVENTIVE HEALTHCARE WITH ONE OF WORLD’S LARGEST RNA DATASETS

Viome's AI-Powered Platform Delivers Personalized Health Insights and Redefines Wellness Worldwide, Integrating Microsoft Azure BELLEVUE, Wash., July 7, 2025 /PRNewswire/…

6 months ago

Precision Genetic Medicine Platform Could Disrupt Standard of Care in Metastatic Cancer, Other Indications of Unmet Needs

NetworkNewsWire Editorial Coverage NEW YORK, July 7, 2025 /PRNewswire/ -- An estimated 20 million people are diagnosed annually with cancer,…

6 months ago

SoundHealth Launches Android App for Its FDA-Approved SONU Band

The first-ever medical-grade Android app that uses a selfie to generate CT-accurate 3D data, the app powers AI-driven, drug-free treatment…

6 months ago

Synfini Adds $8.9 Million Discovery Funding to Speed Small Molecule Drug Development 

Innovative System Combines Physical and Virtual Chemistry with Discovery-Focused AI and Robotic Automation to Find Better Molecules Faster and Less…

6 months ago

SELLAS Life Sciences Appoints Linghua Wang, MD, PhD, to Scientific Advisory Board

NEW YORK, July 07, 2025 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS’’ or the “Company”), a…

6 months ago

Mustang Bio Granted Orphan Drug Designation by U.S. FDA for MB-101 (IL13Ra2-targeted CAR T-cells) to Treat Astrocytomas and Glioblastoma

In an ongoing Phase 1 trial published in Nature Medicine, MB-101 was well-tolerated and 50% of patients achieved stable disease…

6 months ago

Conduit Pharmaceuticals Files New Patents Following AI-Driven Combination Discoveries

Includes Conduit’s first composition of matter patent filing for AZD5658 and multiple new combination filings for AZD1656 and AZD5658Patents derived…

6 months ago